Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer (Q37464715)

20 August 2017

1 reference

title

Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer (English)

1 reference

20 August 2017

1 reference

1 reference

1 reference

Linda A Feagins

1

1 reference

20 August 2017

Rhonda F Souza

series ordinal

2

1 reference

20 August 2017

Stuart J Spechler

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

5

1 reference

20 August 2017

297-305

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2009.44

20 August 2017

0 references

cites work

Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Ulcerative colitis and colorectal cancer. A population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Crohn's disease and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Malignancy in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Cancer risk in patients with inflammatory bowel disease: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Colorectal cancer risk in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

THE CANCER RISK IN ULCERATIVE COLITIS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Malignancy in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Esophageal adenocarcinoma arising in Barrett esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Chronic inflammation and pancreatic cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

The gastritis connection: prevention and early detection of gastric neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

An update on primary sclerosing cholangitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Coordinated defence and the liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Hepatobiliary effects of cholic and lithocholic acids: experimental study in hamsters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Chromosomal and Microsatellite Instability of Adenocarcinomas and Dysplastic Lesions (DALM) in Ulcerative Colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

A novel high-specificity approach for colorectal neoplasia: Detection of K-ras2 oncogene mutation in normal mucosa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Growth factors in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Molecular biology of dysplasia and cancer in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

APC mutations occur early during colorectal tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Chromosomal alterations in ulcerative colitis-related neoplastic progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Increased expression of VEGF and CD146 in patients with inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Self-renewal and solid tumor stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Prospective identification of tumorigenic prostate cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

A tumorigenic subpopulation with stem cell properties in melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Identification of pancreatic cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Identification and expansion of human colon-cancer-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

31 March 2020

Colon cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Phenotypic characterization of human colorectal cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

Identification of stem cells in small intestine and colon by marker gene Lgr5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.44

DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice

31 March 2020

1 reference

12 December 2020

Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression

1 reference

12 December 2020

Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.

1 reference

12 December 2020

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells

1 reference

12 December 2020

Telomerase activity in long-standing ulcerative colitis

1 reference

12 December 2020

Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease

1 reference

12 December 2020

Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis

1 reference

12 December 2020

Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer.

1 reference

12 December 2020

Targeted agents to improve treatment results in colon cancer: bevacizumab and cetuximab.

1 reference

12 December 2020

E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study.

1 reference

12 December 2020

Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease

1 reference

12 December 2020

Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis

1 reference

12 December 2020

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.

1 reference

12 December 2020

Ulcerative proctitis: course and prognosis

1 reference

12 December 2020

DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2009.44

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference